News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Array BioPharma, Inc. (ARRY) to Present at the Lazard Annual Healthcare and Jefferies and Co. 2012 Global Healthcare Conferences


11/8/2012 1:18:55 PM

BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public is welcome to participate in the conferences through webcasts on the Array BioPharma website: www.arraybiopharma.com.

(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)

Event:

Lazard Capital Markets 9th Annual Healthcare Conference

Date:

Tuesday, November 13, 2012

Time:

11:00 a.m. Eastern Time

Location:

The Pierre Hotel, New York, NY



Event:

Jefferies 2012 Global Healthcare Conference

Date:

Thursday, November 15, 2012

Time:

2:20 p.m. Greenwich Mean Time

Location:

London, England

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted smallmolecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two whollyowned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013. For more information on Array, please go to www.arraybiopharma.com.

CONTACT: Tricia Haugeto
Array BioPharma Inc.
303-386-1193
thaugeto@arraybiopharma.com

SOURCE Array BioPharma Inc.


Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES